NCT04330261View on ClinicalTrials.gov

Clinical Characteristics and Outcomes of Pediatric COVID-19

CompletedOBSERVATIONAL
Enrollment

10,610

Participants

Timeline

Start Date

March 18, 2020

Primary Completion Date

June 15, 2021

Study Completion Date

April 5, 2022

Conditions
COVID-19SARS-CoV-2 InfectionPediatric ALLPneumonia, ViralPandemic Response
Interventions
OTHER

Exposure (not intervention) - SARS-CoV-2 infection

Exposure is infection with the virus. There is no intervention

Trial Locations (1)

T3B 6A8

University of Calgary/Alberta Children's Hospital, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT04330261 - Clinical Characteristics and Outcomes of Pediatric COVID-19 | Biotech Hunter | Biotech Hunter